Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,293 | 261 | 64.0% |
| Debt forgiveness | $2,250 | 1 | 33.5% |
| Education | $170.00 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PhotoniCare Inc | $2,295 | 3 | $0 (2024) |
| Novo Nordisk Inc | $738.55 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $534.94 | 37 | $0 (2024) |
| ABBVIE INC. | $481.62 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $466.33 | 20 | $0 (2024) |
| Lilly USA, LLC | $346.08 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $244.83 | 6 | $0 (2024) |
| PFIZER INC. | $183.06 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $182.32 | 12 | $0 (2022) |
| Amgen Inc. | $84.20 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,664 | 79 | PhotoniCare Inc ($2,250) |
| 2023 | $1,025 | 65 | ABBVIE INC. ($169.81) |
| 2022 | $950.07 | 61 | Novo Nordisk Inc ($247.86) |
| 2021 | $1,075 | 59 | Novo Nordisk Inc ($187.50) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PhotoniCare Inc | OtoSight Middle Ear Scope (Device) | Debt forgiveness | In-kind items and services | $2,250.00 | General |
| Category: Diagnostic Imaging | ||||||
| 12/16/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.07 | General |
| 11/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $26.03 | General |
| Category: Medical Device | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.03 | General |
| 09/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: PAIN | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CNS | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,511 | 5,217 | $425,209 | $229,820 |
| 2022 | 16 | 858 | 1,394 | $170,296 | $86,547 |
| 2021 | 18 | 924 | 1,430 | $224,646 | $101,560 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 262 | 1,833 | $117,910 | $71,566 | 60.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 263 | 1,795 | $102,315 | $53,690 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 551 | $73,500 | $42,133 | 57.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 139 | $38,225 | $14,619 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $17,850 | $12,719 | 71.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 75 | 117 | $11,700 | $5,659 | 48.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 110 | 112 | $14,448 | $5,144 | 35.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 27 | $8,100 | $4,587 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 87 | $9,300 | $4,436 | 47.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $5,625 | $3,605 | 64.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 29 | 45 | $8,865 | $3,228 | 36.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $3,345 | $2,418 | 72.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,335 | $1,674 | 38.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,375 | $1,028 | 74.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 24 | $1,920 | $822.72 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 90 | $1,890 | $787.89 | 41.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 21 | $1,575 | $727.02 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 36 | $900.00 | $583.92 | 64.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 27 | $621.00 | $239.50 | 38.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 69 | $1,035 | $151.80 | 14.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 15 | $375.00 | $1.29 | 0.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 474 | $69,690 | $36,665 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 89 | 89 | $14,050 | $9,730 | 69.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 149 | $16,226 | $7,890 | 48.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 82 | 135 | $14,592 | $7,760 | 53.2% |
About Elizabeth Newman, ARNP
Elizabeth Newman, ARNP is a Primary Care healthcare provider based in Lake City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083736615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Newman, ARNP has received a total of $6,713 in payments from pharmaceutical and medical device companies, with $3,664 received in 2024. These payments were reported across 264 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,293).
As a Medicare-enrolled provider, Newman has provided services to 3,293 Medicare beneficiaries, totaling 8,041 services with total Medicare billing of $417,927. Data is available for 3 years (2021–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Lake City, FL
- Active Since 04/04/2007
- Last Updated 03/30/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083736615
Products in Payments
- OtoSight Middle Ear Scope (Device) $2,295
- JARDIANCE (Drug) $396.15
- Rybelsus (Drug) $316.20
- Ozempic (Drug) $312.75
- VRAYLAR (Drug) $254.61
- STIOLTO RESPIMAT (Drug) $164.37
- MOUNJARO (Drug) $151.97
- AIRSUPRA (Drug) $140.40
- UBRELVY (Drug) $135.82
- REXULTI (Drug) $135.06
- SOLIQUA 100/33 (Biological) $126.88
- FASENRA (Biological) $125.00
- BREZTRI (Drug) $117.13
- NURTEC ODT (Drug) $102.27
- FARXIGA (Drug) $83.80
- Korlym (Drug) $83.71
- TRINTELLIX (Drug) $83.39
- QULIPTA (Drug) $81.33
- TRULICITY (Drug) $80.80
- ELIQUIS (Drug) $78.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Lake City
Mary Parrish, Aprn, APRN
Primary Care — Payments: $1,879
Danielle Perry, Aprn, APRN
Primary Care — Payments: $1,023
Mr. Toney Graham, M.d, M.D
Primary Care — Payments: $853.91
Tracie Mitchem-Green, F.n.p, F.N.P
Primary Care
Ms. Casey Perry
Primary Care
Dr. Rene Zambrana, Dnp, Arnp, DNP, ARNP
Primary Care